These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 25713290

  • 1. Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.
    Schisler JC, Grevengoed TJ, Pascual F, Cooper DE, Ellis JM, Paul DS, Willis MS, Patterson C, Jia W, Coleman RA.
    J Am Heart Assoc; 2015 Feb 24; 4(2):. PubMed ID: 25713290
    [Abstract] [Full Text] [Related]

  • 2. Modeling the Transition From Decompensated to Pathological Hypertrophy.
    Pascual F, Schisler JC, Grevengoed TJ, Willis MS, Coleman RA.
    J Am Heart Assoc; 2018 Apr 05; 7(8):. PubMed ID: 29622588
    [Abstract] [Full Text] [Related]

  • 3. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
    Paul DS, Grevengoed TJ, Pascual F, Ellis JM, Willis MS, Coleman RA.
    Biochim Biophys Acta; 2014 Jun 05; 1841(6):880-7. PubMed ID: 24631848
    [Abstract] [Full Text] [Related]

  • 4. Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.
    Ellis JM, Mentock SM, Depetrillo MA, Koves TR, Sen S, Watkins SM, Muoio DM, Cline GW, Taegtmeyer H, Shulman GI, Willis MS, Coleman RA.
    Mol Cell Biol; 2011 Mar 05; 31(6):1252-62. PubMed ID: 21245374
    [Abstract] [Full Text] [Related]

  • 5. Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.
    Grevengoed TJ, Cooper DE, Young PA, Ellis JM, Coleman RA.
    FASEB J; 2015 Nov 05; 29(11):4641-53. PubMed ID: 26220174
    [Abstract] [Full Text] [Related]

  • 6. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR, Carley AN, Ji R, Zhang X, Fasano M, Schulze PC, Lewandowski ED.
    Circulation; 2019 Jun 11; 139(24):2765-2777. PubMed ID: 30909726
    [Abstract] [Full Text] [Related]

  • 7. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
    Zhao L, Pascual F, Bacudio L, Suchanek AL, Young PA, Li LO, Martin SA, Camporez JP, Perry RJ, Shulman GI, Klett EL, Coleman RA.
    J Biol Chem; 2019 May 31; 294(22):8819-8833. PubMed ID: 30975900
    [Abstract] [Full Text] [Related]

  • 8. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
    Goldenberg JR, Wang X, Lewandowski ED.
    J Mol Cell Cardiol; 2016 May 31; 94():1-9. PubMed ID: 26995156
    [Abstract] [Full Text] [Related]

  • 9. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.
    Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, Zaha VG, Dyck JR, Abel ED, Young ME.
    Am J Physiol Heart Circ Physiol; 2006 Jun 31; 290(6):H2480-97. PubMed ID: 16428347
    [Abstract] [Full Text] [Related]

  • 10. Compartmentalized acyl-CoA metabolism in skeletal muscle regulates systemic glucose homeostasis.
    Li LO, Grevengoed TJ, Paul DS, Ilkayeva O, Koves TR, Pascual F, Newgard CB, Muoio DM, Coleman RA.
    Diabetes; 2015 Jan 31; 64(1):23-35. PubMed ID: 25071025
    [Abstract] [Full Text] [Related]

  • 11. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart.
    de Jong H, Neal AC, Coleman RA, Lewin TM.
    Biochim Biophys Acta; 2007 Jan 31; 1771(1):75-82. PubMed ID: 17197235
    [Abstract] [Full Text] [Related]

  • 12. Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function.
    Grevengoed TJ, Martin SA, Katunga L, Cooper DE, Anderson EJ, Murphy RC, Coleman RA.
    J Lipid Res; 2015 Aug 31; 56(8):1572-82. PubMed ID: 26136511
    [Abstract] [Full Text] [Related]

  • 13. Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α.
    Zhu Y, Soto J, Anderson B, Riehle C, Zhang YC, Wende AR, Jones D, McClain DA, Abel ED.
    Am J Physiol Heart Circ Physiol; 2013 Jul 01; 305(1):H41-51. PubMed ID: 23624629
    [Abstract] [Full Text] [Related]

  • 14. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM.
    Am J Physiol Endocrinol Metab; 2008 Feb 01; 294(2):E357-64. PubMed ID: 18042664
    [Abstract] [Full Text] [Related]

  • 15. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift.
    Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M.
    Anesthesiology; 2010 Sep 01; 113(3):541-51. PubMed ID: 20683255
    [Abstract] [Full Text] [Related]

  • 16. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
    Li LO, Ellis JM, Paich HA, Wang S, Gong N, Altshuller G, Thresher RJ, Koves TR, Watkins SM, Muoio DM, Cline GW, Shulman GI, Coleman RA.
    J Biol Chem; 2009 Oct 09; 284(41):27816-27826. PubMed ID: 19648649
    [Abstract] [Full Text] [Related]

  • 17. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
    Das A, Durrant D, Koka S, Salloum FN, Xi L, Kukreja RC.
    J Biol Chem; 2014 Feb 14; 289(7):4145-60. PubMed ID: 24371138
    [Abstract] [Full Text] [Related]

  • 18. Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice.
    de Brouwer KF, Degens H, Aartsen WM, Lindhout M, Bitsch NJ, Gilde AJ, Willemsen PH, Janssen BJ, van der Vusse GJ, van Bilsen M.
    J Mol Cell Cardiol; 2006 Jun 14; 40(6):838-45. PubMed ID: 16697005
    [Abstract] [Full Text] [Related]

  • 19. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
    Aasum E, Cooper M, Severson DL, Larsen TS.
    Can J Physiol Pharmacol; 2005 Feb 14; 83(2):183-90. PubMed ID: 15791292
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes.
    Li LO, Mashek DG, An J, Doughman SD, Newgard CB, Coleman RA.
    J Biol Chem; 2006 Dec 01; 281(48):37246-55. PubMed ID: 17028193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.